Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-07-02 09:18 am Purchase |
2021-06-24 | 13G | ESSA Pharma Inc. EPIX |
RTW Investments, LP | 3,028,719 7.490% |
3,028,719 (New Position) |
Filing History |
| 2021-05-05 5:20 pm Purchase |
2021-04-29 | 13G | ESSA Pharma Inc. EPIX |
BB Biotech AG | 1,985,814 5.100% |
1,985,814 (New Position) |
Filing History |
| 2021-02-16 09:42 am Unchanged |
2020-12-31 | 13G | ESSA Pharma Inc. EPIX |
DRIEHAUS CAPITAL MANAGEMENT LLC | 1,048,524 5.030% |
0 (Unchanged) |
Filing History |
| 2021-02-16 09:15 am Purchase |
2020-12-31 | 13G | ESSA Pharma Inc. EPIX |
DRIEHAUS CAPITAL MANAGEMENT LLC | 1,048,524 5.030% |
1,048,524 (New Position) |
Filing History |
| 2021-02-12 4:30 pm Purchase |
2020-12-31 | 13G | ESSA Pharma Inc. EPIX |
Vivo Capital IX, LLC | 1,562,603 4.700% |
152,089 (+10.78%) |
Filing History |
| 2021-02-12 4:19 pm Purchase |
2020-12-31 | 13G | ESSA Pharma Inc. EPIX |
Eventide Asset Management, LLC | 2,335,168 7.000% |
324,999 (+16.17%) |
Filing History |
| 2021-02-12 4:01 pm Purchase |
2020-12-31 | 13G | ESSA Pharma Inc. EPIX |
Soleus Capital Special Opportunities Fund, L.P. | 3,474,658 9.990% |
630,471 (+22.17%) |
Filing History |
| 2021-02-12 2:32 pm Sale |
2020-12-31 | 13G | ESSA Pharma Inc. EPIX |
Omega Fund IV L.P. | 777,996 2.300% |
-1,004,155 (-56.35%) |
Filing History |
| 2021-02-11 5:20 pm Purchase |
2020-12-31 | 13G | ESSA Pharma Inc. EPIX |
BIOTECHNOLOGY VALUE FUND L P | 3,705,289 11.000% |
1,064,724 (+40.32%) |
Filing History |
| 2020-11-06 4:31 pm Purchase |
2020-10-29 | 13G | ESSA Pharma Inc. EPIX |
Vivo Capital IX, LLC | 1,410,514 4.400% |
1,410,514 (New Position) |
Filing History |
| 2020-08-19 5:14 pm Sale |
2020-08-06 | 13G | ESSA Pharma Inc. EPIX |
ORBIMED ADVISORS LLC | 1,177,483 4.100% |
-294,370 (-20.00%) |
Filing History |
| 2020-08-06 4:22 pm Purchase |
2020-07-31 | 13G | ESSA Pharma Inc. EPIX |
PFIZER INC PFE |
1,675,000 6.000% |
1,675,000 (New Position) |
Filing History |
| 2020-08-03 12:56 pm Purchase |
2020-07-31 | 13G | ESSA Pharma Inc. EPIX |
Soleus Capital Special Opportunities Fund, L.P. | 2,844,187 9.990% |
721,214 (+33.97%) |
Filing History |